
CRVO
Healthcare · Biotechnology · $25.6M market cap
$1.69-0.14 (-7.7%)Nov 13, 4:20 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +36.4% over 90 days · 30-day revisions 3 up, 1 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 6, 2026 | After the close | -0.61 | -0.39 | +36.1% |
| Aug 7, 2026 | Time not confirmed | -0.87 | -0.64 | +26.4% |
| May 19, 2026 | Time not confirmed | -0.79 | -0.86 | -8.5% |
| Mar 13, 2026 | After the close | -0.70 | -0.88 | -25.7% |
| Nov 7, 2025 | After the close | -0.64 | -0.84 | -31.3% |
| Aug 8, 2025 | Before the open | -0.62 | -0.70 | -12.9% |
| Jun 13, 2025 | After the close | -0.62 | -0.56 | +10.2% |
| Mar 17, 2025 | Before the open | -0.63 | -0.80 | -27.0% |
| Nov 12, 2024 | Before the open | -0.41 | -0.55 | -34.1% |
| Aug 9, 2024 | After the close | -0.29 | -0.27 | +6.9% |
| May 14, 2024 | After the close | -0.32 | -0.41 | -28.1% |
| Mar 29, 2024 | After the close | -0.29 | -0.38 | -31.0% |
| Nov 13, 2023 | Before the open | -0.95 |
CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule drug that crosses the blood"brain barrier and inhibits the enzyme p38a. Neflamapimod has the potential to reverse synaptic dysfunction, improve neuron health, and slow or prevent…
| 0.65 |
| +168.4% |
| Aug 8, 2023 | After the close | -2.90 | -1.55 | +46.4% |
| May 15, 2023 | Before the open | -1.91 | -2.01 | -5.2% |
| Mar 21, 2023 | Time not confirmed | -2.22 | -2.00 | +9.9% |
| Nov 14, 2022 | Time not confirmed | -2.06 | -2.06 | 0.0% |
| Aug 11, 2022 | Time not confirmed | -2.04 | -3.09 | -51.5% |
| May 12, 2022 | Time not confirmed | -1.75 | -3.33 | -90.3% |
| Mar 21, 2022 | Time not confirmed | -0.04 | -2.25 | -5525.0% |
| Nov 10, 2021 | Time not confirmed | -0.04 | -9.00 | -22400.0% |
| Aug 11, 2021 | Time not confirmed | -0.04 | -3.00 | -6566.7% |
| May 7, 2021 | Time not confirmed | -0.04 | -4.50 | -9900.0% |
| Mar 17, 2021 | Time not confirmed | -0.06 | -4.50 | -8081.8% |
| Nov 12, 2020 | Time not confirmed | -0.06 | -5.25 | -9445.5% |
| Aug 10, 2020 | Time not confirmed | -0.06 | -7.50 | -12400.0% |
| May 11, 2020 | Time not confirmed | -0.09 | -5.25 | -5733.3% |
| Mar 17, 2020 | Time not confirmed | -0.14 | 21.00 | +15100.0% |
| Nov 11, 2019 | Time not confirmed | -0.71 | -45.00 | -6238.0% |
| Aug 8, 2019 | Time not confirmed | -0.90 | -47.25 | -5150.0% |
| May 9, 2019 | Time not confirmed | -0.91 | -60.75 | -6575.8% |
| Mar 20, 2019 | Time not confirmed | -1.28 | -124.50 | -9626.6% |
| Nov 14, 2018 | Time not confirmed | -0.90 | -146.25 | -16150.0% |
| Aug 13, 2018 | Time not confirmed | -0.06 | -56.25 | -93650.0% |
| Apr 3, 2018 | Time not confirmed | -0.04 | 0.38 | +1050.0% |